Breves S, Di Giammartino D, Nicholson J, Cirigliano S, Mahmood S, Lee U
bioRxiv. 2025; .
PMID: 40034649
PMC: 11875237.
DOI: 10.1101/2024.12.20.629544.
Dong G, Hou Y, Ma Q, Ma S, Wang Y, Rexiati M
World J Clin Cases. 2024; 12(23):5431-5440.
PMID: 39156087
PMC: 11238686.
DOI: 10.12998/wjcc.v12.i23.5431.
Dashi G, Varjosalo M
Oncologist. 2024; 30(1).
PMID: 38833619
PMC: 11783282.
DOI: 10.1093/oncolo/oyae126.
Ebegboni V, Jones T, Brownmiller T, Zhao P, Pehrsson E, Sundara Rajan S
Mol Cancer Res. 2024; 22(7):625-641.
PMID: 38588446
PMC: 11219265.
DOI: 10.1158/1541-7786.MCR-23-1090.
Ruzanov P, Evdokimova V, Pachva M, Minkovich A, Zhang Z, Langman S
J Clin Invest. 2024; 134(9).
PMID: 38530366
PMC: 11060741.
DOI: 10.1172/JCI169470.
ETS1, a target gene of the EWSR1::FLI1 fusion oncoprotein, regulates the expression of the focal adhesion protein TENSIN3.
Ebegboni V, Jones T, Brownmiller T, Zhao P, Pehrsson E, Sundara Rajan S
bioRxiv. 2024; .
PMID: 38187702
PMC: 10769395.
DOI: 10.1101/2023.12.21.572864.
Bioinformatic Analysis of Recurrent Genomic Alterations and Corresponding Pathway Alterations in Ewing Sarcoma.
Rock A, Uche A, Yoon J, Agulnik M, Chow W, Millis S
J Pers Med. 2023; 13(10).
PMID: 37888109
PMC: 10608227.
DOI: 10.3390/jpm13101499.
Hedgehog pathway in sarcoma: from preclinical mechanism to clinical application.
Banaszek N, Kurpiewska D, Kozak K, Rutkowski P, Sobczuk P
J Cancer Res Clin Oncol. 2023; 149(19):17635-17649.
PMID: 37815662
PMC: 10657326.
DOI: 10.1007/s00432-023-05441-3.
Surface and Global Proteome Analyses Identify ENPP1 and Other Surface Proteins as Actionable Immunotherapeutic Targets in Ewing Sarcoma.
Mooney B, Negri G, Shyp T, Delaidelli A, Zhang H, Spencer Miko S
Clin Cancer Res. 2023; 30(5):1022-1037.
PMID: 37812652
PMC: 10905525.
DOI: 10.1158/1078-0432.CCR-23-2187.
Practical Management of Adult Ultra-Rare Primary Retroperitoneal Soft Tissue Sarcoma: A Focus on Perivascular Epithelioid Tumours and Extraosseous Ewing Sarcoma.
Apte S, Mor E, Mitchell C, Gyorki D
Curr Oncol. 2023; 30(7):5953-5972.
PMID: 37504306
PMC: 10377910.
DOI: 10.3390/curroncol30070445.
Children's Oncology Group's 2023 blueprint for research: Bone tumors.
Reed D, Grohar P, Rubin E, Binitie O, Krailo M, Davis J
Pediatr Blood Cancer. 2023; 70 Suppl 6:e30583.
PMID: 37501549
PMC: 10499366.
DOI: 10.1002/pbc.30583.
Unusual Manifestation of Extraosseous Ewing Sarcoma: Report of 3 Cases.
Ioannidou M, Tsotridou E, Samoladas E, Tragiannidis A, Kouskouras K, Sfougaris D
Balkan J Med Genet. 2023; 25(2):77-81.
PMID: 37265973
PMC: 10230840.
DOI: 10.2478/bjmg-2022-0022.
Exosome-Based Liquid Biopsy Approaches in Bone and Soft Tissue Sarcomas: Review of the Literature, Prospectives, and Hopes for Clinical Application.
Agnoletto C, Pignochino Y, Caruso C, Garofalo C
Int J Mol Sci. 2023; 24(6).
PMID: 36982236
PMC: 10048895.
DOI: 10.3390/ijms24065159.
Transcriptional Regulation during Aberrant Activation of NF-κB Signalling in Cancer.
Deka K, Li Y
Cells. 2023; 12(5).
PMID: 36899924
PMC: 10001244.
DOI: 10.3390/cells12050788.
Screening for DAX1/EWS-FLI1 functional inhibitors identified dihydroorotate dehydrogenase as a therapeutic target for Ewing's sarcoma.
Watanabe M, Kosaka H, Sugawara M, Maemoto M, Ono Y, Uemori T
Cancer Med. 2023; 12(8):9802-9814.
PMID: 36825574
PMC: 10166890.
DOI: 10.1002/cam4.5741.
Extraskeletal Ewing sarcoma of the sciatic nerve.
Heller D, Wasilewski G, Mustafa J, Chaudhry H, Lowery E, Borys D
Radiol Case Rep. 2023; 18(3):1221-1226.
PMID: 36660563
PMC: 9842801.
DOI: 10.1016/j.radcr.2022.12.006.
Systematic multi-omics cell line profiling uncovers principles of Ewing sarcoma fusion oncogene-mediated gene regulation.
Orth M, Surdez D, Faehling T, Ehlers A, Marchetto A, Grossetete S
Cell Rep. 2022; 41(10):111761.
PMID: 36476851
PMC: 10333306.
DOI: 10.1016/j.celrep.2022.111761.
Neomorphic DNA-binding enables tumor-specific therapeutic gene expression in fusion-addicted childhood sarcoma.
Holting T, Cidre-Aranaz F, Matzek D, Popper B, Jacobi S, Funk C
Mol Cancer. 2022; 21(1):199.
PMID: 36229873
PMC: 9558418.
DOI: 10.1186/s12943-022-01641-6.
An international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcoma.
Shulman D, Whittle S, Surdez D, Bailey K, de Alava E, Yustein J
NPJ Precis Oncol. 2022; 6(1):65.
PMID: 36115869
PMC: 9482616.
DOI: 10.1038/s41698-022-00307-2.
Clinical implementation of plasma cell-free circulating tumor DNA quantification by digital droplet PCR for the monitoring of Ewing sarcoma in children and adolescents.
Seidel M, Kashofer K, Moser T, Thueringer A, Liegl-Atzwanger B, Leithner A
Front Pediatr. 2022; 10:926405.
PMID: 36046479
PMC: 9420963.
DOI: 10.3389/fped.2022.926405.